WO1998041256A2 - Inhalation device - Google Patents

Inhalation device Download PDF

Info

Publication number
WO1998041256A2
WO1998041256A2 PCT/SE1998/000457 SE9800457W WO9841256A2 WO 1998041256 A2 WO1998041256 A2 WO 1998041256A2 SE 9800457 W SE9800457 W SE 9800457W WO 9841256 A2 WO9841256 A2 WO 9841256A2
Authority
WO
WIPO (PCT)
Prior art keywords
inhaler
inhaler according
mouthpiece
cap
powder
Prior art date
Application number
PCT/SE1998/000457
Other languages
French (fr)
Other versions
WO1998041256A3 (en
Inventor
Jan Andersson
John Conway
Allan Dagsland
Stefan Friess
Harald Heckenmueller
Uwe Rollwage
Hans Strid
Volker Tiedemann
Jan Trofast
Original Assignee
Astra Aktiebolag (Publ)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26662934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1998041256(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9700937A external-priority patent/SE9700937D0/en
Priority claimed from SE9703829A external-priority patent/SE9703829D0/en
Priority to IL16540098A priority Critical patent/IL165400A0/en
Priority to EP98909946A priority patent/EP1017438B1/en
Priority to AU64303/98A priority patent/AU741505B2/en
Priority to CA002283258A priority patent/CA2283258C/en
Priority to SK1234-99A priority patent/SK285517B6/en
Priority to UA99095001A priority patent/UA68344C2/en
Priority to BR9811456-5A priority patent/BR9811456A/en
Priority to EEP199900403A priority patent/EE04420B1/en
Priority to NZ337478A priority patent/NZ337478A/en
Priority to PL98369035A priority patent/PL190261B1/en
Priority to KR10-1999-7008296A priority patent/KR100492839B1/en
Priority to JP54042398A priority patent/JP4138019B2/en
Priority to IL13154798A priority patent/IL131547A0/en
Application filed by Astra Aktiebolag (Publ) filed Critical Astra Aktiebolag (Publ)
Priority to SI9830700T priority patent/SI1017438T1/en
Priority to DK98909946T priority patent/DK1017438T3/en
Priority to US09/066,319 priority patent/US6655380B1/en
Priority to AT98909946T priority patent/ATE275998T1/en
Priority to DE69826299T priority patent/DE69826299T2/en
Priority to TR2000/01837T priority patent/TR200001837T2/en
Priority to PL98335799A priority patent/PL188765B1/en
Priority to HU0000840A priority patent/HU223792B1/en
Publication of WO1998041256A2 publication Critical patent/WO1998041256A2/en
Publication of WO1998041256A3 publication Critical patent/WO1998041256A3/en
Priority to NO19994432A priority patent/NO321728B1/en
Priority to IS5178A priority patent/IS2780B/en
Priority to US10/673,689 priority patent/US7841340B2/en
Priority to US11/125,615 priority patent/US7228860B2/en
Priority to US11/940,346 priority patent/US7779836B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001Particle size control
    • A61M11/002Particle size control by flow deviation causing inertial separation of transported particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0005Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • A61M15/0068Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007Mechanical counters
    • A61M15/0071Mechanical counters having a display or indicator
    • A61M15/0076Mechanical counters having a display or indicator on a drum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/14Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Definitions

  • the present invention relates to a powder inhaler for administering powder by inhalation.
  • a number of powder inhalers which use different systems for introducing a dose of powder into an air stream.
  • the powder is inhaled into the lungs of a patient in order to treat, for example, asthma.
  • This inhaler comprises an inhalation channel and a mouthpiece comprising an air chamber and an outlet nozzle, which together define a flow path through which a stream of air is drawn during inhalation by a user.
  • This inhaler further comprises means for introducing powder into the inhalation channel. During inhalation, air is first drawn into and through the inhalation channel so as to pick up powder. The stream of air containing powder is then drawn through the air chamber and out of the outlet nozzle of the mouthpiece.
  • FIG. 1 illustrates such a powder inhaler.
  • the inhaler comprises a mouthpiece 2 comprising an outlet nozzle 4, an inhaler body 6 and a rotatable grip portion 8 for operating a dosing mechanism for providing doses of powder for inhalation.
  • the inhaler body 6 is provided with an opening 10 which is filled with a window 12 through which an indicating wheel 42 is visible so as to provide an indication as to the usage of the inhaler.
  • Figure 2 illustrates in exploded view component parts disposed within and to the inhaler body 6.
  • the inhaler body 6 is capped with a divider 14 which is fixed thereto.
  • the divider 14 is a transparent moulding which has a depending tongue 15, a part of which forms the window 12.
  • the component parts of the dosing mechanism include a dosing unit 16 which comprises a member 17 having a planar surface in which a plurality of dosing means 18 are provided and a shaft 20 which extends axially from the centre of the member 17, an inhalation unit 22 which comprises an inhalation channel 24 and a storage unit 26 which comprises a storage chamber 28 for storing powder.
  • the above-mentioned component parts of the dosing mechanism are assembled by passing the inhalation channel 24 through an opening 30 in the storage unit 26 and passing the shaft 20 through central openings 32, 34 in the inhalation unit 22 and the storage unit 26 respectively.
  • the upper ends of the inhalation channel 24 and the storage chamber 28 pass respectively through first and second openings 36, 38 in the divider 14.
  • the inhalation unit 22 and the storage unit 26 are fixed in position in relation to one another and the dosing unit 16 can be rotated relative thereto.
  • the storage unit 28 is open at the bottom such that in use powder is provided to the dosing unit 16 under the action of gravity and the inhalation unit 22 further comprises scrapers 40 which are resiliently biased against the surface of the member 17 in which the dosing means 18 are provided.
  • the dosing means 18, which in this inhaler comprise a plurality of through holes, are filled with powder by the scrapers 40. Powder is prevented from passing through the dosing means 18 by a plate (not illustrated) which is disposed beneath the dosing unit 16.
  • the divider 14 further comprises supporting means 41 for rotatably supporting an indicating wheel 42.
  • the indicating wheel 42 has a plurality of teeth 44 disposed around the periphery thereof which engage with a spiral groove or protrusion 46 on the end face of the shaft 20.
  • the supporting means 41 is configured to align the indicating wheel 42 such that a part of the periphery thereof is disposed adjacent the inner surface of the window 12. In use, as the dosing unit 16 is rotated, the spiral groove or protrusion 46 engages with one or more of the teeth 44 on the indicating wheel 42 so as to rotate the same.
  • the mouthpiece 2 is fixed to the divider 14.
  • the mouthpiece 2 comprises first and second parts 48, 50, the first part 48 being the part which is gripped by the lips of a user and the second part 50 being an insert fitted within the first part 48.
  • the second part 50 comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
  • the dosing unit 16 In use. as described hereinabove, powder is transferred from the storage chamber 28 to one of the dosing means 18, and, with rotation of the dosing unit 16, the one dosing means 18 provides a dose of powder to the inhalation channel 24.
  • the dosing unit 16 is rotated by rotating the grip portion 8 in the counter-clockwise sense between first and second angularly-spaced positions.
  • the dosing unit 16 comprises wedge- shaped elements 60 disposed around the periphery of the member 17 and the grip portion 8 comprises a resilient member (not illustrated) which is configured to engage with an axially-directed surface 60a of a respective one of the wedge-shaped elements 60 so as to rotate the dosing unit 16 by pushing the respective wedge-shaped element 60.
  • the dosing unit 16 On rotation of the grip portion 8 in the opposite, clockwise, sense between the second and the first angularly-spaced positions, the dosing unit 16 remains stationary and the resilient member is located behind the axially-directed surface 60a of the adjacent wedge-shaped element 60; the resilient member riding over an inclined surface 60b of the adjacent wedge-shaped element 60.
  • the present invention provides a powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means.
  • the present invention also provides a powder inhaler for admimstering powder by inhalation, comprising: a housing having a screw thread; a mouthpiece attached to the housing so as to be rotatable relative thereto; and a cap for covering at least the mouthpiece, the cap having a screw thread for engaging the screw thread on the housing; characterized in that the mouthpiece and the cap are adapted such that at least a part of the mouthpiece is rotated relative to the housing on one of screwing or unscrewing the cap, which part of the mouthpiece substantially remains in fixed position relative to the housing on the other of screwing or unscrewing the cap.
  • powder which may have accumulated on inner surfaces of the inhaler is dislodged from those surfaces prior to the next inhalation. Powder is thus prevented from accumulating within the inhaler beyond a single use. In this way, any variation in the dose of powder delivered is limited to the amount of powder retained after a single use. This amount will, however, be very small and relatively insignificant.
  • the powder inhaler of the present invention may be used with any suitable form of powder, including powders introduced into the air stream in the raw state or as conglomerate, micronised or ordered mixture particles.
  • the active ingredient or ingredients of the powder may be diluted with one or more substances such as lactose and may include substances for the treatment of various conditions, not necessarily respiratory conditions.
  • the powder can include genetic material and need not be restricted to human use only.
  • Medicaments suitable for administration by the powder inhaler of the present invention are any which may be delivered by inhalation and include for example ⁇ 2-adrenoreceptor agonists, for example, salbutamol. terbutaline. rimiterol, fenoterol, reproterol. adrenaline, pirbuterol.
  • antiallergic medicaments for example, sodium cromoglycate and nedocromil sodium; expectorants; mucolytics; antihistamines; cyclooxygenase inhibitors; leukotriene synthesis inhibitors; leukotriene antagonists; phospholipase-A2 (PLA2) inhibitors; platelet aggregating factor (PAF) antagonists and prophylactics of asthma; antiarrhythmic medicaments; tranquilisers; cardiac glycosides; hormones; antihypertensive medicaments; antidiabetic medicaments; antiparasitic medicaments; anticancer medicaments; sedatives; analgesic medicaments; antibiotics; antirheumatic medicaments; immunotherapies; antifungal medicaments; antihypotension
  • Figure 1 illustrates a perspective view of a known powder inhaler
  • Figure 2 illustrates in exploded view component parts of the inhaler of Figure 1;
  • Figure 3 illustrates the underside of the mouthpiece of the inhaler of Figure 1 ;
  • Figure 4 illustrates a part-sectional side view of the inhaler of Figure 1 ;
  • Figure 5 illustrates a perspective view of a powder inhaler in accordance with a first embodiment of the present invention (with the mouthpiece illustrated in phantom);
  • Figure 6(a) illustrates a powder inhaler in accordance with a second embodiment of the present invention (with the mouthpiece illustrated in phantom);
  • Figure 6(b) illustrates the underside of the mouthpiece and the loose element of the inhaler of Figure 6(a);
  • Figure 7 illustrates a powder inhaler in accordance with a third embodiment of the present invention (with part of the mouthpiece illustrated in phantom);
  • Figure 8 illustrates in exploded view a powder inhaler in accordance with a fourth embodiment of the present invention
  • Figure 9 illustrates in exploded view a powder inhaler in accordance with a fifth embodiment of the present invention
  • Figure 10 illustrates in exploded view a powder inhaler in accordance with a sixth embodiment of the present invention.
  • Figure 1 1 illustrates in exploded view a powder inhaler in accordance with a seventh embodiment of the present invention
  • Figure 12 illustrates a perspective view of a powder inhaler in accordance with an eighth embodiment of the present invention (with the mouthpiece illustrated in phantom);
  • Figure 13 illustrates in exploded view a powder inhaler in accordance with a ninth embodiment of the present invention.
  • Figure 14 illustrates in exploded view the component parts of the mouthpiece of the inhaler of Figure 13;
  • Figure 15 illustrates a plan view of part of the cover plate of the inhaler of Figure 13;
  • Figure 16 illustrates the cap for the inhaler of Figure 13
  • Figure 17 illustrates the cap and the mouthpiece of a powder inhaler in accordance with a tenth embodiment of the present invention (with part of the cap illustrated in phantom);
  • Figure 18 illustrates a powder inhaler in accordance with an eleventh embodiment of the present invention (with part of the mouthpiece illustrated in phantom).
  • the powder inhalers in accordance with the preferred embodiments of the present invention have many features in common with the known powder inhaler described hereinabove in relation to Figures 1 to 4. For this reason and in order to avoid unnecessary duplication of description, only the structural differences will be described in detail and reference is made to the preceding description of the known powder inhaler.
  • FIG. 5 illustrates a powder inhaler in accordance with a first embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in further comprising a plurality of flexible elements 62 in the form of fingers disposed around the inlet to the air chamber 58, that is, around the outlet of the inhalation channel 24.
  • the flexible elements 62 are configured, when caused to move by a stream of air flowing through the inhaler on inhalation by a user, to contact at least a part of a surface defining the flow path.
  • the flexible elements 62 are of such a length as to contact the surface of the air chamber 58 defined by the second part 50 of the mouthpiece 2 during movement and thereby dislodge any powder which may have accumulated on that surface.
  • FIGS 6(a) and 6(b) illustrate a powder inhaler in accordance with a second embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in further comprising a loose element 64 which is freely movable within the air chamber 58 and in that the upper surface of the divider 14 is formed as a generally flat surface having few or no surface discontinuities.
  • the divider 14 of this embodiment can be compared with the divider 14 of the above-described known powder inhaler whose upper surface is irregular. It will be appreciated that by forming the upper surface of the divider 14 as a generally flat surface there are fewer possible sites in which powder may accumulate and the loose element 64 cannot contact.
  • the loose element 64 can be of any suitable shape and material.
  • a ring has been identified as a particularly suitable form since this form provides a large area of contact with both the upper and lower surfaces of the air chamber 58 without impeding air flow.
  • the loose element 64 is moved within the air chamber 58 and thereby any powder which may have accumulated on inner surfaces thereof is dislodged.
  • the loose element 64 is formed of a relatively dense material, for example a metal, such that impact of the loose element 64 against inner surfaces of the air chamber 58 induces vibrations in the inhaler, in particular in the second part 50 of the mouthpiece 2, which additionally act to dislodge any powder which may have accumulated on surfaces of the flow path.
  • FIG. 7 illustrates a powder inhaler in accordance with a third embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 66, 68, 70 and a biasing means 72, preferably a compression spring, for axially biasing the first and second parts 66, 68 towards one another.
  • a biasing means 72 preferably a compression spring
  • the first part 66 similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially-directed flange 56, the lower surface of which together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
  • the first part 66 differs from the second part 50 of the above-described known powder inhaler in that the upper surface of the flange 56 is provided with a plurality of axially-directed projections 74, in this embodiment of triangular cross-section, each with a first flank 74a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 74b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above.
  • the projections 74 are disposed about the periphery of the flange 56.
  • the projections 74 can each be formed as a radial sector.
  • the second part 68 is rotatable relative to the first part 66 and is rotatably fixed in relation to the third part 70.
  • the second part 68 comprises a plate of substantially the same radial dimension as the flange 56 of the first part 66.
  • the lower surface of the second part 68 is provided with a plurality of axially-directed projections 78, the cross-section of which in this embodiment is complimentary to the projections 74 on the flange 56 of the first part 66.
  • the projections 78 are of triangular cross-section, each with a first flank 78a which faces in one sense, in this embodiment in the counter-clockwise sense when viewed from above, and a second flank 78b which faces in the opposite sense, in this embodiment in the clockwise sense when viewed from above.
  • the projections 78 are disposed about the periphery of the second part 68.
  • the projections 78 can each be formed as a radial sector.
  • the third part 70 similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is clipped to the divider 14 and is the part which is gripped by the lips of a user.
  • the second part 68 which is rotated concomitantly therewith is axially displaced away from the first part 66 as the first flanks 78a of the projections 78 on the second part 68 ride along the respective first flanks 74a of the projections 74 on the flange 56 of the first part 66.
  • the second part 68 is further axially displaced away from the flange 56 of the first part 66 until the point is reached where the trailing edges of the first flanks 78a of the projections 78 on the second part 68 pass beyond the leading edges of the first flanks 74a of the respective projections 74 on the flange 56 of the first part 66.
  • the second part 68 is rapidly driven axially under the action of the biasing means 72 into contact with the flange 56 of the first part 66.
  • This sharp contact between the projections 78 on the second part 68 and the projections 74 on the flange 56 of the first part 66 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 66, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 that defines the upper surface of the air chamber 58.
  • Figure 8 illustrates a powder inhaler in accordance with a fourth embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 80, 82, 84.
  • the first part 80 similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially-directed flange 56.
  • the first part 80 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 86 disposed about the periphery of the flange 56 by which the first part 80 is clipped to the divider 14 and a plurality of axially-directed projections 88 on the upper surface of the flange 56. each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52.
  • each of the projections 88 comprises a first flank 88a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 88b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above.
  • the second part 82 comprises a tubular section 90 which is located over the tubular section 52 of the first part 80, a flange 92 which extends radially from the tubular section 90 and an element 94 which is connected to the flange 92 by a resilient arm 96 and is configured to ride over the projections 88.
  • the flange 92 includes a downwardly-directed peripheral extension 98 by which the second part 82 is clipped to the first part 80 so that the flanges 56.
  • the second part 82 is fitted to the first part 80 so as to be rotatable in one sense relative thereto, in this embodiment in the counter-clockwise sense when viewed from above.
  • the third part 84 similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user. In this embodiment the third part 84 is fixed to the second part 82 such that the second part 82 rotates concomitantly therewith.
  • the element 94 rides along the first flank 88a of one of the projections 88 and is displaced axially away from the flange 56 of the first part 80.
  • the resilient arm 96 is progressively deflected.
  • the element 94 is further axially displaced until the element 94 passes beyond the leading edge of the first flank 88a of the respective projection 88. At that point, the element 94 is rapidly driven under the action of the loaded arm 96 into contact with the flange 56 of the first part 80.
  • FIG. 9 illustrates a powder inhaler in accordance with a fifth embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • the mouthpiece 2 comprises first and second parts 100, 102.
  • the first part 100 similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
  • the first part 100 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 104 disposed about the periphery of the flange 56 by which the first part 100 is clipped to the divider 14 and a plurality of radially- directed projections 106, each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52.
  • the second part 102 similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user.
  • the second part 102 comprises an inwardly-directed member 108, the distal end of which is configured to engage the projections 106 disposed about tubular section 52.
  • the member 108 is deflected radially outwardly on riding over a first flank 106a of one of the projections 106.
  • the member 108 is progressively deflected until passing beyond the leading edge of the first flank 106a of the respective projection 106. At that point, the distal end of the member 108 which is under load is rapidly driven radially inwardly into contact with the first flank 106a of the adjacent projection 106.
  • the member 108 is formed of a resilient material. It will be appreciated, however, that the member 108 could be formed of a rigid material and biased against the tubular section 52 by a biasing means such as a spring.
  • Figure 10 illustrates a powder inhaler in accordance with a sixth embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 110, 112, 114.
  • the first part 110 similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
  • the first part 110 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 116 disposed about the periphery of the flange 56 by which the first part 1 10 is clipped to the divider 14 and a plurality of upwardly- directed axial projections 118, each in this embodiment in the form of a stub of circular cross- section, disposed at a distance about the outer periphery of the tubular section 52.
  • the projections 118 are equi-spaced on a circle about the tubular section 52.
  • the second part 112 comprises a tubular section 120 which is located over the tubular section 52 of the first part 110 and a plurality of members 122 which extend at least in part radially outwardly from the tubular section 120.
  • the second part 112 is fixed to the third part 114 so as to rotate concomitantly therewith and the third part 1 14 is clipped to the first part 1 10 so as to be rotatable relative thereto.
  • the members 122 each ride over a respective one of the projections 118 and are deflected radially inwardly. With continued rotation, the elements 122 are progressively deflected and thereby biased until the distal ends thereof pass beyond the respective projections 118. At that point, the distal ends of the members 122 are rapidly driven radially outwardly and contact each of the respective adjacent projections 118.
  • Figure 1 1 illustrates a powder inhaler in accordance with a seventh embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 124, 126, 128.
  • the first part 124 similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
  • the first part 124 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 130 disposed about the periphery of the flange 56 by which the first part 124 is clipped to the divider 14 and a plurality of axially- directed projections 132, each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52.
  • each of the projections 132 comprises a first flank 132a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 132b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above.
  • the first part 124 further differs from the second part 50 of the above-described known powder inhaler in that at least a part of the flange 56 is formed of a resilient material such that the tubular section 52 can be moved axially relative to the peripheral extension 130 and thereby resiliently deform the flange 56.
  • the flange 56 is formed of sufficiently small thickness in order to exhibit the necessary resiliency to allow for deformation.
  • the second part 126 comprises a tubular section 134 which is located over the tubular section 52 of the first part 124, a flange 136 which extends radially from the tubular section 134 and a downwardly-directed extension 138 disposed about the periphery of the flange 136 by which the second part 126 is clipped to the first part 124 so as to be rotatable thereto.
  • the outer periphery of the extension 138 is provided with a plurality of radially-directed projections 140 which act as a grip for a user.
  • the second part 126 further comprises a plurality of axially- directed projections (not illustrated) disposed to the lower surface of the flange 136, the cross-section of which projections is in this embodiment complimentary to the projections 132 disposed about the periphery of the tubular section 52 of the first part 66.
  • the projections on the lower surface of the flange 136 are of triangular cross- section, each with a first flank which faces in one sense, in this embodiment in the counterclockwise sense when viewed from above, and a second flank which faces in the opposite sense, in this embodiment in the clockwise sense when viewed form above.
  • the second part 126 is fitted to the first part 124 so as to be rotatable in one sense relative thereto, in this embodiment in the counter-clockwise sense when viewed from above.
  • the tubular section 52 is displaced downwardly axially relative to the extension 130 as the first flanks of the projections on the lower surface of the flange 136 ride along the first flanks 132a of the respective projections 132 on the tubular section 52.
  • the tubular section 52 is further axially displaced until the trailing edges of the first flanks of the projections on the lower surface of the flange 136 pass beyond the leading edges of the first flanks 132a of the respective projections 132 on the tubular section 52.
  • the tubular section 52 is returned rapidly to the original axial position and the projections 132 on the tubular section 52 contact the projections on the lower surface of the flange 136.
  • This sharp contact between the projections 132 on the tubular section 52 and the projections on the lower surface of the flange 136 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 124, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 which defines the upper surface of the air chamber 58.
  • Figure 12 illustrates a powder inhaler in accordance with an eighth embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in ⁇ further comprising a member 142 disposed to the upper surface of the divider 14 which contacts the lower surface of the second part 50 of the mouthpiece 2 defining a part of the air chamber 58.
  • the member 142 comprises a scraper or a brush.
  • the mouthpiece 2 is rotatable relative to the inhaler body 6.
  • the member 142 acts to dislodge powder which may have accumulated on the lower surface of the second part 50.
  • the member 142 can be formed as an integral part of the plug or be attached to the plug. It will be appreciated that whilst in this embodiment the member 142 is configured to contact the lower surface of the second part 50 which defines an upper surface of the air chamber 58, in an alternative embodiment the member 142 could instead be configured to contact the upper surface of the divider 14 which defines the lower surface of the air chamber 58.
  • FIG. 13 illustrates a powder inhaler in accordance with a ninth embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • This embodiment differs from the above-described known powder inhaler in that the divider 14 further comprises a supplementary air inlet 142 which is in fluid communication with an opening 144 in the peripheral wall of the inhaler body 6 and in further comprising a cover plate 146 which is located above the divider 14.
  • the cover plate 146 comprises first and second openings 148, 150 which correspond respectively to the inhalation channel 24 and the supplementary air inlet 142.
  • the cover plate 146 further comprises an outwardly-biased element 152 which is connected to the main body thereof by a resilient arm 154.
  • the element 152 has an end face 152a which is substantially radially directed.
  • the cover plate 146 still further comprises a member 156 which is configured to contact a part of the lower surface of the flange 56 defining the upper surface of the air chamber 58.
  • the member 156 comprises one of a scraper or a brush.
  • the member 156 is integrally formed with the cover plate 146 and comprises an arm which is formed of resilient material and acts as a scraper.
  • the mouthpiece 2 comprises first and second parts 158, 160.
  • first part 158 further comprises a plurality of radially inwardly-directed projections 162 and a plurality of radially outwardly-directed projections 164.
  • Each of the projections 162 comprises a first flank 162a which faces in one sense, in this embodiment in the counterclockwise sense when viewed from above, and a second flank 162b which faces in the other sense, in this embodiment in the clockwise sense when viewed form above.
  • the second flanks 162b of the projections 162 are substantially radially directed.
  • the inhaler is configured such that the mouthpiece 2 cannot be freely rotated relative to the inhaler body 6, which would be undesirable when a user was trying to grip the mouthpiece 2 in the lips.
  • the mouthpiece 2 is attached to the inhaler body 6 by means of clips 166 which engage a ridge 168 that is formed about the periphery of the divider 14.
  • the inhaler is configured so as to allow the mouthpiece 2 to be rotated in the counter-clockwise sense on the application of a relatively small force, but to provide significant resistance to rotation of the mouthpiece 2 in the clockwise sense and thereby permit only forced rotation in that sense.
  • the element 152 rides over the first flanks 162a of the projections 162 on the application of a relatively low force, with the resilient arm 154 being deflected radially inwardly.
  • the end face 152a of the element 152 abuts the second flank 162b of one of the projections 162, which end face 152a and second flanks 162b of the projections 162 are formed so as to provide surfaces at a small angle relative to the radial direction.
  • a relatively high force has to be applied to overcome the resistance between the end face 152a of the element 152 the second flank 162b of the respective projection 162.
  • the inhaler could be configured to prevent the mouthpiece 2 being rotated in one sense by providing the end face 152a of the element 152 and the second flanks 162b of the projections 162 as radially-directed surfaces, in this embodiment it has been recognized that a user could attempt to force the mouthpiece 2 to rotate in that sense which may lead to damage being caused such as by deforming any of the element 152, the resilient arm 154 or the projections 162.
  • the lower surface of the flange 56 of the second part 160 is rotated relative to the member 156 thereby causing powder which may have accumulated on that part of the lower surface of the flange 56 immediately upstream of the member 156 in a rotational sense to be removed.
  • the inhaler further comprises a cap 168 which is adapted to rotate the mouthpiece 2 on removal.
  • the cap 168 includes a plurality of resilient members 170 disposed about the inner periphery thereof which engage with the outwardly- directed projections 164 on the first part 158 of the mouthpiece 2.
  • the members 170 extend axially and enclose an acute angle with the inner periphery of the cap 168; the distal ends of the members 170 being directed in the counter-clockwise sense when viewed from above.
  • the members 170 engage the outwardly-directed projections 164 on the first part 158 for the entire period that the cap 168 is removed, in this embodiment by unscrewing in the counter-clockwise sense when viewed from above.
  • one or more of the members 170 engage respective projections 164 on the first part 158 and cause the mouthpiece 2 to be rotated relative to the inhaler body 6, thereby causing the member 156 to remove powder which may have accumulated on that part of the lower surface of the flange 56 upstream, in a rotational sense, of the member 156.
  • the mouthpiece 2 is automatically rotated. Further, the mouthpiece 2 is rotated in only one direction and only when the cap 168 is removed.
  • This arrangement has a number of advantages. Specifically, in that powder is dislodged immediately prior to inhalation.
  • the grip portion 8 is tended to be rotated in the sense opposite to that required to provide a dose of powder to the inhalation channel 24.
  • the members 170 are deflected and ride over the respective projections 164 on the first part 158.
  • the cap 168 is provided with a greater number of members 170 than the first part 158 is provided with projections 164. In this way, the angle through which the cap 168 has to be rotated before engaging one or more of the projections 164 is minimized.
  • the members 170 pass over the projections 164 one at a time, such that with the cap 168 fitted no more than one member 170 can be left in a deformed state; extended periods of deformation being undesirable in causing relaxation of the material of the members 170.
  • the cap 168 and the members 170 are formed as an integral moulding.
  • Figure 17 illustrates the cap and the mouthpiece of a powder inhaler in accordance with a tenth embodiment of the present invention.
  • This embodiment incorporates an alternative construction for rotating the mouthpiece of an inhaler on removing the cap.
  • a plurality of axially-directed grooves 172 are provided in the periphery of the mouthpiece 2 and the cap 168 is provided with an insert 174 disposed in an upper portion thereof.
  • the insert 174 is in the shape of a ring and comprises a plurality of radially inwardly-biased members 176 which are configured to engage with the grooves 172 in the mouthpiece 2.
  • the distal ends of the members 176 are directed in the counter-clockwise sense when viewed from above.
  • the members 176 In use, when the cap 168 is removed, in this embodiment by unscrewing in the counter-clockwise sense when viewed from above, the members 176 locate in respective grooves 172 and cause the mouthpiece 2 to be rotated relative to the inhaler body 6. In this way, whenever a user removes the cap 168 the mouthpiece 2 is automatically rotated. In fitting the cap 168, in this embodiment by screwing in the clockwise sense, the members 176 are deflected and ride over the grooves 172.
  • Figure 18 illustrates a powder inhaler in accordance with an eleventh embodiment of the present invention.
  • This embodiment is a modification of the above-described known powder inhaler.
  • the mouthpiece 2 similarly to the above-described known powder inhaler, the mouthpiece 2 comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder.
  • This embodiment differs from the above-described known powder inhaler in comprising a cap 168 which includes a brush 178 that extends from the lower surface of the upper end thereof.
  • the brush 178 is located along the longitudinal axis of the cap 168 such that when the cap 168 is fitted, in this embodiment by screwing in the clockwise sense, the brush 178 extends into the tubular section 52. In this way, whenever the cap 168 is fitted or removed, the brush 178 acts to dislodge powder which may have accumulated within the tubular section 52.
  • the brush 178 is formed in a spiral or helical shape so as more effectively to clean the surfaces of the spirally or helically shaped projections 54 within the tubular section 52.
  • the brush 178 can be mounted to the cap 168 so as to allow relative rotation.
  • the present invention may provide inhalers in which vibrations are created using electrical power.
  • a piezoelectric element can be used to create vibrations for dislodging powder which may have accumulated.
  • the piezoelectric element can be driven by a battery or by movement of part of the inhaler, for example by rotation of the mouthpiece as described hereinabove.
  • an electrostatic field can be used to dislodge powder which may have accumulated.
  • the present invention may provide inhalers in which vibrations are created by parts which cooperate.
  • a detented surface may be provided between the mouthpiece and the inhaler body such that vibrations are created on relative axial movement thereof.
  • the cap and the mouthpiece or the inhaler body can be provided with a detented surface therebetween such that on fitting the cap, for example by a push fit or a screw fit, vibrations are created.

Abstract

A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).

Description

INHALATION DEVICE
The present invention relates to a powder inhaler for administering powder by inhalation.
A number of powder inhalers are known which use different systems for introducing a dose of powder into an air stream. Typically, the powder is inhaled into the lungs of a patient in order to treat, for example, asthma.
One such powder inhaler is disclosed in EP-A-0237507. This inhaler comprises an inhalation channel and a mouthpiece comprising an air chamber and an outlet nozzle, which together define a flow path through which a stream of air is drawn during inhalation by a user. This inhaler further comprises means for introducing powder into the inhalation channel. During inhalation, air is first drawn into and through the inhalation channel so as to pick up powder. The stream of air containing powder is then drawn through the air chamber and out of the outlet nozzle of the mouthpiece.
Figure 1 illustrates such a powder inhaler. The inhaler comprises a mouthpiece 2 comprising an outlet nozzle 4, an inhaler body 6 and a rotatable grip portion 8 for operating a dosing mechanism for providing doses of powder for inhalation. The inhaler body 6 is provided with an opening 10 which is filled with a window 12 through which an indicating wheel 42 is visible so as to provide an indication as to the usage of the inhaler.
Figure 2 illustrates in exploded view component parts disposed within and to the inhaler body 6. The inhaler body 6 is capped with a divider 14 which is fixed thereto. For aesthetic reasons the inhaler body 6 is an opaque moulding. The divider 14 is a transparent moulding which has a depending tongue 15, a part of which forms the window 12.
Within the inhaler body 6 are housed the component parts of the dosing mechanism. These component parts include a dosing unit 16 which comprises a member 17 having a planar surface in which a plurality of dosing means 18 are provided and a shaft 20 which extends axially from the centre of the member 17, an inhalation unit 22 which comprises an inhalation channel 24 and a storage unit 26 which comprises a storage chamber 28 for storing powder. The above-mentioned component parts of the dosing mechanism are assembled by passing the inhalation channel 24 through an opening 30 in the storage unit 26 and passing the shaft 20 through central openings 32, 34 in the inhalation unit 22 and the storage unit 26 respectively. When so assembled, the upper ends of the inhalation channel 24 and the storage chamber 28 pass respectively through first and second openings 36, 38 in the divider 14. In this way, the inhalation unit 22 and the storage unit 26 are fixed in position in relation to one another and the dosing unit 16 can be rotated relative thereto.
In this inhaler the storage unit 28 is open at the bottom such that in use powder is provided to the dosing unit 16 under the action of gravity and the inhalation unit 22 further comprises scrapers 40 which are resiliently biased against the surface of the member 17 in which the dosing means 18 are provided. In this way, as the dosing unit 16 is rotated, the dosing means 18, which in this inhaler comprise a plurality of through holes, are filled with powder by the scrapers 40. Powder is prevented from passing through the dosing means 18 by a plate (not illustrated) which is disposed beneath the dosing unit 16.
As illustrated in Figure 2, the divider 14 further comprises supporting means 41 for rotatably supporting an indicating wheel 42. The indicating wheel 42 has a plurality of teeth 44 disposed around the periphery thereof which engage with a spiral groove or protrusion 46 on the end face of the shaft 20. The supporting means 41 is configured to align the indicating wheel 42 such that a part of the periphery thereof is disposed adjacent the inner surface of the window 12. In use, as the dosing unit 16 is rotated, the spiral groove or protrusion 46 engages with one or more of the teeth 44 on the indicating wheel 42 so as to rotate the same. In this way, by providing a coloured marking on the periphery of the indicating wheel 42, it is possible to provide the user with a visible indication at the window 12 as to the usage of the inhaler. As illustrated in Figure 4, the mouthpiece 2 is fixed to the divider 14. The mouthpiece 2 comprises first and second parts 48, 50, the first part 48 being the part which is gripped by the lips of a user and the second part 50 being an insert fitted within the first part 48. The second part 50 comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user.
In use. as described hereinabove, powder is transferred from the storage chamber 28 to one of the dosing means 18, and, with rotation of the dosing unit 16, the one dosing means 18 provides a dose of powder to the inhalation channel 24. In this inhaler the dosing unit 16 is rotated by rotating the grip portion 8 in the counter-clockwise sense between first and second angularly-spaced positions. For this purpose the dosing unit 16 comprises wedge- shaped elements 60 disposed around the periphery of the member 17 and the grip portion 8 comprises a resilient member (not illustrated) which is configured to engage with an axially-directed surface 60a of a respective one of the wedge-shaped elements 60 so as to rotate the dosing unit 16 by pushing the respective wedge-shaped element 60. On rotation of the grip portion 8 in the opposite, clockwise, sense between the second and the first angularly-spaced positions, the dosing unit 16 remains stationary and the resilient member is located behind the axially-directed surface 60a of the adjacent wedge-shaped element 60; the resilient member riding over an inclined surface 60b of the adjacent wedge-shaped element 60.
Although the above-described known powder inhaler functions quite adequately, powder may accumulate on surfaces in the flow path through the inhaler. It is thus an aim of the present invention to provide a powder inhaler having a construction which is such as to reduce the possibility of powder accumulating on surfaces in the flow path therethrough.
Accordingly, the present invention provides a powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means.
The present invention also provides a powder inhaler for admimstering powder by inhalation, comprising: a housing having a screw thread; a mouthpiece attached to the housing so as to be rotatable relative thereto; and a cap for covering at least the mouthpiece, the cap having a screw thread for engaging the screw thread on the housing; characterized in that the mouthpiece and the cap are adapted such that at least a part of the mouthpiece is rotated relative to the housing on one of screwing or unscrewing the cap, which part of the mouthpiece substantially remains in fixed position relative to the housing on the other of screwing or unscrewing the cap.
By virtue of the present invention, powder which may have accumulated on inner surfaces of the inhaler is dislodged from those surfaces prior to the next inhalation. Powder is thus prevented from accumulating within the inhaler beyond a single use. In this way, any variation in the dose of powder delivered is limited to the amount of powder retained after a single use. This amount will, however, be very small and relatively insignificant.
In addition, by configuring the inhaler such that the mouthpiece is rotated automatically when the cap is removed, it is not necessary to rely upon the user to remember to rotate the mouthpiece prior to each inhalation. The powder inhaler of the present invention may be used with any suitable form of powder, including powders introduced into the air stream in the raw state or as conglomerate, micronised or ordered mixture particles. Furthermore, the active ingredient or ingredients of the powder may be diluted with one or more substances such as lactose and may include substances for the treatment of various conditions, not necessarily respiratory conditions. Indeed, the powder can include genetic material and need not be restricted to human use only.
Medicaments suitable for administration by the powder inhaler of the present invention are any which may be delivered by inhalation and include for example β2-adrenoreceptor agonists, for example, salbutamol. terbutaline. rimiterol, fenoterol, reproterol. adrenaline, pirbuterol. isoprenaline, orciprenaline, bitolterol, salmeterol, formoterol, clenbuterol, procaterol, broxaterol, picumeterol, TA-2005, mabuterol and the like, and their pharmacologically acceptable esters and salts; anticholinergic bronchodilators, for example, ipratropium bromide and the like; glucocorticosteroids, for example. beclomethasone, fluticasone. budesonide, tipredane, dexamethasone, betamethasone, fluocinolone, triamcinolone acetonide, mometasone and the like, and their pharmacologically acceptable esters and salts; antiallergic medicaments, for example, sodium cromoglycate and nedocromil sodium; expectorants; mucolytics; antihistamines; cyclooxygenase inhibitors; leukotriene synthesis inhibitors; leukotriene antagonists; phospholipase-A2 (PLA2) inhibitors; platelet aggregating factor (PAF) antagonists and prophylactics of asthma; antiarrhythmic medicaments; tranquilisers; cardiac glycosides; hormones; antihypertensive medicaments; antidiabetic medicaments; antiparasitic medicaments; anticancer medicaments; sedatives; analgesic medicaments; antibiotics; antirheumatic medicaments; immunotherapies; antifungal medicaments; antihypotension medicaments; vaccines; antiviral medicaments; proteins; polypeptides and peptides, for example, peptide hormones and growth factors; polypeptide vaccines; enzymes; endorphines; lipoproteins and polypeptides involved in the blood coagulation cascade: vitamins; and others, for example, cell surface receptor blockers, antioxidants, free radical scavengers and organic salts of N,N'-diacetylcystine.
Preferred embodiments of the present invention will now be described hereinbelow by way of example only with reference to the accompanying drawings, in which:
Figure 1 illustrates a perspective view of a known powder inhaler;
Figure 2 illustrates in exploded view component parts of the inhaler of Figure 1;
Figure 3 illustrates the underside of the mouthpiece of the inhaler of Figure 1 ;
Figure 4 illustrates a part-sectional side view of the inhaler of Figure 1 ;
Figure 5 illustrates a perspective view of a powder inhaler in accordance with a first embodiment of the present invention (with the mouthpiece illustrated in phantom);
Figure 6(a) illustrates a powder inhaler in accordance with a second embodiment of the present invention (with the mouthpiece illustrated in phantom);
Figure 6(b) illustrates the underside of the mouthpiece and the loose element of the inhaler of Figure 6(a);
Figure 7 illustrates a powder inhaler in accordance with a third embodiment of the present invention (with part of the mouthpiece illustrated in phantom);
Figure 8 illustrates in exploded view a powder inhaler in accordance with a fourth embodiment of the present invention; Figure 9 illustrates in exploded view a powder inhaler in accordance with a fifth embodiment of the present invention;
Figure 10 illustrates in exploded view a powder inhaler in accordance with a sixth embodiment of the present invention;
Figure 1 1 illustrates in exploded view a powder inhaler in accordance with a seventh embodiment of the present invention;
Figure 12 illustrates a perspective view of a powder inhaler in accordance with an eighth embodiment of the present invention (with the mouthpiece illustrated in phantom);
Figure 13 illustrates in exploded view a powder inhaler in accordance with a ninth embodiment of the present invention;
Figure 14 illustrates in exploded view the component parts of the mouthpiece of the inhaler of Figure 13;
Figure 15 illustrates a plan view of part of the cover plate of the inhaler of Figure 13;
Figure 16 illustrates the cap for the inhaler of Figure 13;
Figure 17 illustrates the cap and the mouthpiece of a powder inhaler in accordance with a tenth embodiment of the present invention (with part of the cap illustrated in phantom); and
Figure 18 illustrates a powder inhaler in accordance with an eleventh embodiment of the present invention (with part of the mouthpiece illustrated in phantom).
Structurally, the powder inhalers in accordance with the preferred embodiments of the present invention have many features in common with the known powder inhaler described hereinabove in relation to Figures 1 to 4. For this reason and in order to avoid unnecessary duplication of description, only the structural differences will be described in detail and reference is made to the preceding description of the known powder inhaler.
Figure 5 illustrates a powder inhaler in accordance with a first embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in further comprising a plurality of flexible elements 62 in the form of fingers disposed around the inlet to the air chamber 58, that is, around the outlet of the inhalation channel 24. The flexible elements 62 are configured, when caused to move by a stream of air flowing through the inhaler on inhalation by a user, to contact at least a part of a surface defining the flow path. In a preferred embodiment the flexible elements 62 are of such a length as to contact the surface of the air chamber 58 defined by the second part 50 of the mouthpiece 2 during movement and thereby dislodge any powder which may have accumulated on that surface.
Figures 6(a) and 6(b) illustrate a powder inhaler in accordance with a second embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in further comprising a loose element 64 which is freely movable within the air chamber 58 and in that the upper surface of the divider 14 is formed as a generally flat surface having few or no surface discontinuities. The divider 14 of this embodiment can be compared with the divider 14 of the above-described known powder inhaler whose upper surface is irregular. It will be appreciated that by forming the upper surface of the divider 14 as a generally flat surface there are fewer possible sites in which powder may accumulate and the loose element 64 cannot contact. The loose element 64 can be of any suitable shape and material.
However, a ring has been identified as a particularly suitable form since this form provides a large area of contact with both the upper and lower surfaces of the air chamber 58 without impeding air flow. In use, with movement of the inhaler, the loose element 64 is moved within the air chamber 58 and thereby any powder which may have accumulated on inner surfaces thereof is dislodged. In a preferred embodiment the loose element 64 is formed of a relatively dense material, for example a metal, such that impact of the loose element 64 against inner surfaces of the air chamber 58 induces vibrations in the inhaler, in particular in the second part 50 of the mouthpiece 2, which additionally act to dislodge any powder which may have accumulated on surfaces of the flow path.
Figure 7 illustrates a powder inhaler in accordance with a third embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 66, 68, 70 and a biasing means 72, preferably a compression spring, for axially biasing the first and second parts 66, 68 towards one another. The first part 66, similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially-directed flange 56, the lower surface of which together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user. The first part 66 differs from the second part 50 of the above-described known powder inhaler in that the upper surface of the flange 56 is provided with a plurality of axially-directed projections 74, in this embodiment of triangular cross-section, each with a first flank 74a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 74b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above. In this embodiment the projections 74 are disposed about the periphery of the flange 56. In another embodiment the projections 74 can each be formed as a radial sector. The second part 68 is rotatable relative to the first part 66 and is rotatably fixed in relation to the third part 70. The second part 68 comprises a plate of substantially the same radial dimension as the flange 56 of the first part 66. The lower surface of the second part 68 is provided with a plurality of axially-directed projections 78, the cross-section of which in this embodiment is complimentary to the projections 74 on the flange 56 of the first part 66. In this embodiment the projections 78 are of triangular cross-section, each with a first flank 78a which faces in one sense, in this embodiment in the counter-clockwise sense when viewed from above, and a second flank 78b which faces in the opposite sense, in this embodiment in the clockwise sense when viewed from above. In this embodiment the projections 78 are disposed about the periphery of the second part 68. In another embodiment the projections 78 can each be formed as a radial sector. The third part 70, similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is clipped to the divider 14 and is the part which is gripped by the lips of a user. In use, on rotation of the third part 70, the second part 68 which is rotated concomitantly therewith is axially displaced away from the first part 66 as the first flanks 78a of the projections 78 on the second part 68 ride along the respective first flanks 74a of the projections 74 on the flange 56 of the first part 66. With continued rotation of the third part 70, the second part 68 is further axially displaced away from the flange 56 of the first part 66 until the point is reached where the trailing edges of the first flanks 78a of the projections 78 on the second part 68 pass beyond the leading edges of the first flanks 74a of the respective projections 74 on the flange 56 of the first part 66. At that point, the second part 68 is rapidly driven axially under the action of the biasing means 72 into contact with the flange 56 of the first part 66. This sharp contact between the projections 78 on the second part 68 and the projections 74 on the flange 56 of the first part 66 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 66, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 that defines the upper surface of the air chamber 58. It will be appreciated that whilst this preferred embodiment incorporates axially-directed projections 74, 78 of triangular cross-section, other cross-sections which would achieve the effect of inducing vibrations in the inhaler, particularly in the first part 66, could also be equally used.
Figure 8 illustrates a powder inhaler in accordance with a fourth embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 80, 82, 84. The first part 80, similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially-directed flange 56. which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user. The first part 80 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 86 disposed about the periphery of the flange 56 by which the first part 80 is clipped to the divider 14 and a plurality of axially-directed projections 88 on the upper surface of the flange 56. each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52. In this embodiment each of the projections 88 comprises a first flank 88a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 88b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above. The second part 82 comprises a tubular section 90 which is located over the tubular section 52 of the first part 80, a flange 92 which extends radially from the tubular section 90 and an element 94 which is connected to the flange 92 by a resilient arm 96 and is configured to ride over the projections 88. The flange 92 includes a downwardly-directed peripheral extension 98 by which the second part 82 is clipped to the first part 80 so that the flanges 56. 92 have a fixed axial relationship. The second part 82 is fitted to the first part 80 so as to be rotatable in one sense relative thereto, in this embodiment in the counter-clockwise sense when viewed from above. The third part 84, similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user. In this embodiment the third part 84 is fixed to the second part 82 such that the second part 82 rotates concomitantly therewith. In this way, on rotation of the third part 84 in one sense, in this embodiment in the counter-clockwise sense when viewed from above, the element 94 rides along the first flank 88a of one of the projections 88 and is displaced axially away from the flange 56 of the first part 80. As the element 94 is displaced the resilient arm 96 is progressively deflected. The element 94 is further axially displaced until the element 94 passes beyond the leading edge of the first flank 88a of the respective projection 88. At that point, the element 94 is rapidly driven under the action of the loaded arm 96 into contact with the flange 56 of the first part 80. This sharp contact between the element 94 and the flange 56 of the first part 80 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 80. and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 which defines the upper surface of the air chamber 58.
Figure 9 illustrates a powder inhaler in accordance with a fifth embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. In this embodiment the mouthpiece 2 comprises first and second parts 100, 102. The first part 100, similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user. The first part 100 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 104 disposed about the periphery of the flange 56 by which the first part 100 is clipped to the divider 14 and a plurality of radially- directed projections 106, each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52. The second part 102, similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user. In this embodiment the second part 102 comprises an inwardly-directed member 108, the distal end of which is configured to engage the projections 106 disposed about tubular section 52. In this way, on rotation of the second part 102 relative to the first part 100, in this embodiment in the counter-clockwise sense when viewed from above, the member 108 is deflected radially outwardly on riding over a first flank 106a of one of the projections 106. The member 108 is progressively deflected until passing beyond the leading edge of the first flank 106a of the respective projection 106. At that point, the distal end of the member 108 which is under load is rapidly driven radially inwardly into contact with the first flank 106a of the adjacent projection 106. This sharp contact between the distal end of the member 108 and the tubular section 52 induces vibrations in the inhaler, in particular in the first part 100, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 which defines the upper surface of the air chamber 58. In this embodiment the member 108 is formed of a resilient material. It will be appreciated, however, that the member 108 could be formed of a rigid material and biased against the tubular section 52 by a biasing means such as a spring.
Figure 10 illustrates a powder inhaler in accordance with a sixth embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 110, 112, 114. The first part 110, similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user. The first part 110 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 116 disposed about the periphery of the flange 56 by which the first part 1 10 is clipped to the divider 14 and a plurality of upwardly- directed axial projections 118, each in this embodiment in the form of a stub of circular cross- section, disposed at a distance about the outer periphery of the tubular section 52. In this embodiment the projections 118 are equi-spaced on a circle about the tubular section 52. The second part 112 comprises a tubular section 120 which is located over the tubular section 52 of the first part 110 and a plurality of members 122 which extend at least in part radially outwardly from the tubular section 120. The third part 1 14, similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user. In this embodiment the second part 112 is fixed to the third part 114 so as to rotate concomitantly therewith and the third part 1 14 is clipped to the first part 1 10 so as to be rotatable relative thereto. In this way, on rotation of the third part 1 14 in one sense, in this embodiment in the counter-clockwise sense when viewed from above, the members 122 each ride over a respective one of the projections 118 and are deflected radially inwardly. With continued rotation, the elements 122 are progressively deflected and thereby biased until the distal ends thereof pass beyond the respective projections 118. At that point, the distal ends of the members 122 are rapidly driven radially outwardly and contact each of the respective adjacent projections 118. This sharp contact between the members 122 and the projections 1 18 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 1 10, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 which defines the upper surface of the air chamber 58.
Figure 1 1 illustrates a powder inhaler in accordance with a seventh embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in that the mouthpiece 2 comprises first, second and third parts 124, 126, 128. The first part 124, similarly to the second part 50 of the mouthpiece 2 of the above-described known powder inhaler, comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder, and a substantially radially- directed flange 56, which provides a surface that together with upper surface of the divider 14 defines an air chamber 58 that is in fluid communication with the inhalation channel 24 through which air containing powder is drawn on inhalation by a user. The first part 124 differs from the second part 50 of the above-described known powder inhaler in further comprising a downwardly-directed extension 130 disposed about the periphery of the flange 56 by which the first part 124 is clipped to the divider 14 and a plurality of axially- directed projections 132, each in this embodiment of triangular cross-section, disposed about the outer periphery of the tubular section 52. In this embodiment each of the projections 132 comprises a first flank 132a which faces in one sense, in this embodiment in the clockwise sense when viewed from above, and a second flank 132b which faces in the opposite sense, in this embodiment in the counter-clockwise sense when viewed from above. The first part 124 further differs from the second part 50 of the above-described known powder inhaler in that at least a part of the flange 56 is formed of a resilient material such that the tubular section 52 can be moved axially relative to the peripheral extension 130 and thereby resiliently deform the flange 56. In a preferred embodiment the flange 56 is formed of sufficiently small thickness in order to exhibit the necessary resiliency to allow for deformation. In this embodiment the second part 126 comprises a tubular section 134 which is located over the tubular section 52 of the first part 124, a flange 136 which extends radially from the tubular section 134 and a downwardly-directed extension 138 disposed about the periphery of the flange 136 by which the second part 126 is clipped to the first part 124 so as to be rotatable thereto. In this embodiment the outer periphery of the extension 138 is provided with a plurality of radially-directed projections 140 which act as a grip for a user. The second part 126 further comprises a plurality of axially- directed projections (not illustrated) disposed to the lower surface of the flange 136, the cross-section of which projections is in this embodiment complimentary to the projections 132 disposed about the periphery of the tubular section 52 of the first part 66. In this embodiment the projections on the lower surface of the flange 136 are of triangular cross- section, each with a first flank which faces in one sense, in this embodiment in the counterclockwise sense when viewed from above, and a second flank which faces in the opposite sense, in this embodiment in the clockwise sense when viewed form above. The second part 126 is fitted to the first part 124 so as to be rotatable in one sense relative thereto, in this embodiment in the counter-clockwise sense when viewed from above. The third part 128, similarly to the first part 48 of the mouthpiece 2 of the above-described known powder inhaler, is the part which is gripped by the lips of a user. In this embodiment the third part 128 is fixed to the second part 126 so as to rotate concomitantly therewith. In this way, on rotation of one of the second part 126 or the third part 128 in one sense, in this embodiment in the counter-clockwise sense when viewed from above, the tubular section 52 is displaced downwardly axially relative to the extension 130 as the first flanks of the projections on the lower surface of the flange 136 ride along the first flanks 132a of the respective projections 132 on the tubular section 52. The tubular section 52 is further axially displaced until the trailing edges of the first flanks of the projections on the lower surface of the flange 136 pass beyond the leading edges of the first flanks 132a of the respective projections 132 on the tubular section 52. At that point, the tubular section 52 is returned rapidly to the original axial position and the projections 132 on the tubular section 52 contact the projections on the lower surface of the flange 136. This sharp contact between the projections 132 on the tubular section 52 and the projections on the lower surface of the flange 136 which is achieved by the rapid movement induces vibrations in the inhaler, in particular in the first part 124, and thereby dislodges powder which may have accumulated on the lower surface of the flange 56 which defines the upper surface of the air chamber 58.
Figure 12 illustrates a powder inhaler in accordance with an eighth embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in further comprising a member 142 disposed to the upper surface of the divider 14 which contacts the lower surface of the second part 50 of the mouthpiece 2 defining a part of the air chamber 58. In preferred embodiments the member 142 comprises a scraper or a brush. In this embodiment the mouthpiece 2 is rotatable relative to the inhaler body 6. In use, on rotating the second part 50 relative to the member 142, in this embodiment by rotating the mouthpiece 2, the member 142 acts to dislodge powder which may have accumulated on the lower surface of the second part 50. In a preferred embodiment, where the top of the storage chamber 28 includes an inlet which is closed by a separate plug, the member 142 can be formed as an integral part of the plug or be attached to the plug. It will be appreciated that whilst in this embodiment the member 142 is configured to contact the lower surface of the second part 50 which defines an upper surface of the air chamber 58, in an alternative embodiment the member 142 could instead be configured to contact the upper surface of the divider 14 which defines the lower surface of the air chamber 58. In another embodiment one or more members 142 could be provided which are configured to contact both the lower surface of the second part 50 and the upper surface of the divider 14. Figure 13 illustrates a powder inhaler in accordance with a ninth embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. This embodiment differs from the above-described known powder inhaler in that the divider 14 further comprises a supplementary air inlet 142 which is in fluid communication with an opening 144 in the peripheral wall of the inhaler body 6 and in further comprising a cover plate 146 which is located above the divider 14. The cover plate 146 comprises first and second openings 148, 150 which correspond respectively to the inhalation channel 24 and the supplementary air inlet 142. The cover plate 146 further comprises an outwardly-biased element 152 which is connected to the main body thereof by a resilient arm 154. In this embodiment the element 152 has an end face 152a which is substantially radially directed. The cover plate 146 still further comprises a member 156 which is configured to contact a part of the lower surface of the flange 56 defining the upper surface of the air chamber 58. In preferred embodiments the member 156 comprises one of a scraper or a brush. In this embodiment the member 156 is integrally formed with the cover plate 146 and comprises an arm which is formed of resilient material and acts as a scraper. In this embodiment the mouthpiece 2 comprises first and second parts 158, 160. This embodiment further differs from the above-described known powder inhaler in that the first part 158 further comprises a plurality of radially inwardly-directed projections 162 and a plurality of radially outwardly-directed projections 164. Each of the projections 162 comprises a first flank 162a which faces in one sense, in this embodiment in the counterclockwise sense when viewed from above, and a second flank 162b which faces in the other sense, in this embodiment in the clockwise sense when viewed form above. In this embodiment the second flanks 162b of the projections 162 are substantially radially directed. In this way, the inhaler is configured such that the mouthpiece 2 cannot be freely rotated relative to the inhaler body 6, which would be undesirable when a user was trying to grip the mouthpiece 2 in the lips. In this embodiment the mouthpiece 2 is attached to the inhaler body 6 by means of clips 166 which engage a ridge 168 that is formed about the periphery of the divider 14. In this embodiment the inhaler is configured so as to allow the mouthpiece 2 to be rotated in the counter-clockwise sense on the application of a relatively small force, but to provide significant resistance to rotation of the mouthpiece 2 in the clockwise sense and thereby permit only forced rotation in that sense. On rotating the mouthpiece 2 in the counter-clockwise sense the element 152 rides over the first flanks 162a of the projections 162 on the application of a relatively low force, with the resilient arm 154 being deflected radially inwardly. On rotating the mouthpiece 2 in the clockwise sense the end face 152a of the element 152 abuts the second flank 162b of one of the projections 162, which end face 152a and second flanks 162b of the projections 162 are formed so as to provide surfaces at a small angle relative to the radial direction. In order to rotate the element 152 beyond the respective projection 162, a relatively high force has to be applied to overcome the resistance between the end face 152a of the element 152 the second flank 162b of the respective projection 162. Whilst the inhaler could be configured to prevent the mouthpiece 2 being rotated in one sense by providing the end face 152a of the element 152 and the second flanks 162b of the projections 162 as radially-directed surfaces, in this embodiment it has been recognized that a user could attempt to force the mouthpiece 2 to rotate in that sense which may lead to damage being caused such as by deforming any of the element 152, the resilient arm 154 or the projections 162. In use, on rotating the mouthpiece 2 relative to the inhaler body 6, the lower surface of the flange 56 of the second part 160 is rotated relative to the member 156 thereby causing powder which may have accumulated on that part of the lower surface of the flange 56 immediately upstream of the member 156 in a rotational sense to be removed.
In a preferred embodiment the inhaler further comprises a cap 168 which is adapted to rotate the mouthpiece 2 on removal. In this embodiment the cap 168 includes a plurality of resilient members 170 disposed about the inner periphery thereof which engage with the outwardly- directed projections 164 on the first part 158 of the mouthpiece 2. The members 170 extend axially and enclose an acute angle with the inner periphery of the cap 168; the distal ends of the members 170 being directed in the counter-clockwise sense when viewed from above. By having an axial length the members 170 engage the outwardly-directed projections 164 on the first part 158 for the entire period that the cap 168 is removed, in this embodiment by unscrewing in the counter-clockwise sense when viewed from above. In use, when the cap 168 is removed, one or more of the members 170 engage respective projections 164 on the first part 158 and cause the mouthpiece 2 to be rotated relative to the inhaler body 6, thereby causing the member 156 to remove powder which may have accumulated on that part of the lower surface of the flange 56 upstream, in a rotational sense, of the member 156. In this way, whenever a user removes the cap 168 the mouthpiece 2 is automatically rotated. Further, the mouthpiece 2 is rotated in only one direction and only when the cap 168 is removed. This arrangement has a number of advantages. Specifically, in that powder is dislodged immediately prior to inhalation. In addition, on removing the cap 168, the grip portion 8 is tended to be rotated in the sense opposite to that required to provide a dose of powder to the inhalation channel 24. Thus, there is no risk of a user loading the inhaler on removing the cap 168. In fitting the cap 168, in this embodiment by screwing in the clockwise sense, the members 170 are deflected and ride over the respective projections 164 on the first part 158. In a preferred embodiment the cap 168 is provided with a greater number of members 170 than the first part 158 is provided with projections 164. In this way, the angle through which the cap 168 has to be rotated before engaging one or more of the projections 164 is minimized. In addition, when the cap 168 is fitted, the members 170 pass over the projections 164 one at a time, such that with the cap 168 fitted no more than one member 170 can be left in a deformed state; extended periods of deformation being undesirable in causing relaxation of the material of the members 170. In a preferred embodiment the cap 168 and the members 170 are formed as an integral moulding.
Figure 17 illustrates the cap and the mouthpiece of a powder inhaler in accordance with a tenth embodiment of the present invention. This embodiment incorporates an alternative construction for rotating the mouthpiece of an inhaler on removing the cap. In this embodiment a plurality of axially-directed grooves 172 are provided in the periphery of the mouthpiece 2 and the cap 168 is provided with an insert 174 disposed in an upper portion thereof. The insert 174 is in the shape of a ring and comprises a plurality of radially inwardly-biased members 176 which are configured to engage with the grooves 172 in the mouthpiece 2. The distal ends of the members 176 are directed in the counter-clockwise sense when viewed from above. In use, when the cap 168 is removed, in this embodiment by unscrewing in the counter-clockwise sense when viewed from above, the members 176 locate in respective grooves 172 and cause the mouthpiece 2 to be rotated relative to the inhaler body 6. In this way, whenever a user removes the cap 168 the mouthpiece 2 is automatically rotated. In fitting the cap 168, in this embodiment by screwing in the clockwise sense, the members 176 are deflected and ride over the grooves 172.
Figure 18 illustrates a powder inhaler in accordance with an eleventh embodiment of the present invention. This embodiment is a modification of the above-described known powder inhaler. In this embodiment, similarly to the above-described known powder inhaler, the mouthpiece 2 comprises a tubular section 52, which includes one or more spirally or helically shaped projections 54 that act to deflect the air drawn therethrough and thereby deagglomerate any larger particles of entrained powder. This embodiment differs from the above-described known powder inhaler in comprising a cap 168 which includes a brush 178 that extends from the lower surface of the upper end thereof. The brush 178 is located along the longitudinal axis of the cap 168 such that when the cap 168 is fitted, in this embodiment by screwing in the clockwise sense, the brush 178 extends into the tubular section 52. In this way, whenever the cap 168 is fitted or removed, the brush 178 acts to dislodge powder which may have accumulated within the tubular section 52. In a preferred embodiment the brush 178 is formed in a spiral or helical shape so as more effectively to clean the surfaces of the spirally or helically shaped projections 54 within the tubular section 52. In another embodiment the brush 178 can be mounted to the cap 168 so as to allow relative rotation.
In further embodiments the present invention may provide inhalers in which vibrations are created using electrical power. In one embodiment a piezoelectric element can be used to create vibrations for dislodging powder which may have accumulated. The piezoelectric element can be driven by a battery or by movement of part of the inhaler, for example by rotation of the mouthpiece as described hereinabove. In another embodiment an electrostatic field can be used to dislodge powder which may have accumulated. In yet further embodiments the present invention may provide inhalers in which vibrations are created by parts which cooperate. In one embodiment a detented surface may be provided between the mouthpiece and the inhaler body such that vibrations are created on relative axial movement thereof. In another embodiment the cap and the mouthpiece or the inhaler body can be provided with a detented surface therebetween such that on fitting the cap, for example by a push fit or a screw fit, vibrations are created.
Finally, it will be understood by a person skilled in the art that the present invention has been described in its preferred embodiments and can be modified in many different ways without departing from the scope of the invention as defined in the appended claims.

Claims

1. A powder inhaler for administering powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in use drawn on inhalation by a user; and dosing means (18) for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises dislodging means for dislodging powder accumulated on a surface of the flow path downstream of the dosing means (18).
2. The inhaler according to claim 1, wherein the flow path includes a chamber (58) having an inlet and an outlet.
3. The inhaler according to claim 2, wherein the dislodging means is adapted to contact a surface defining at least a part of the chamber (58).
4. The inhaler according to claim 2 or 3, wherein the dislodging means comprises a loose element (64) disposed within the chamber (58) which is configured so as not to obstruct the stream of air drawn through the chamber (58) during inhalation by the user.
5. The inhaler according to claim 4, wherein the loose element (64) comprises a ring.
6. The inhaler according to claim 4 or 5, wherein the loose element (64) is composed of a metal.
7. The inhaler according to claim 2 or 3, wherein the dislodging means comprises a plurality of flexible elements (62) disposed at the inlet to the chamber (58), the flexible elements (62) being of such length and flexibility to contact a surface defining at least a part of the chamber (58) during inhalation by the user.
8. The inhaler according to claim 2 or 3, wherein the inlet and the outlet to the chamber (58) are formed in opposed surfaces that are relatively rotatable in relation to one another and the dislodging means comprises a member (142; 156) which is fixed in relation to one of the opposed surfaces and is configured to contact the other of the opposed surfaces so as to dislodge powder accumulated on the other of the opposed surfaces on relative rotation of the opposed surfaces.
9. The inhaler according to claim 8, wherein the member (142; 156) comprises one of a scraper or a brush.
10. The inhaler according to claim 8 or 9, further comprising a storage chamber (28) for storing a plurality of doses of powder, the storage chamber (28) having a filling inlet in one of the opposed surfaces of the chamber (58), and a plug for sealing the filling inlet, wherein the member (142) is formed as a part of or attached to the plug.
11. The inhaler according to claim 1 or 2, wherein the dislodging means is adapted to create vibrations in the inhaler.
12. The inhaler according to claim 1 1, wherein the dislodging means comprises first and second relatively movable components (66, 68; 80, 82; 100, 102; 110, 112; 124, 126), each having cooperating surfaces (74, 78; 88, 94; 106, 108; 118, 122; 132) which are resiliently biased towards one another, at least one of the cooperating surfaces (74; 88; 106; 118; 132) having one or more discontinuities such that as the first and second components (66, 68; 80, 82; 100, 102; 110, 112; 124, 126) are moved relative to one another vibrations are created in the inhaler.
13. The inhaler according to claim 12, wherein the at least one of the cooperating surfaces (74; 88; 106; 132) has a saw-tooth cross-section.
14. The inhaler according to claim 12 or 13, wherein the other of the cooperating surfaces (94; 108; 122) is provided on a resiliently-biased arm.
15. The inhaler according to any of claims 12 to 14, wherein the first and second components (66, 68; 80, 82; 100, 102; 110, 112; 124, 126) are relatively rotatable.
16. The inhaler according to claim 15, wherein the at least one of the cooperating surfaces (74; 88; 106; 1 18; 132) generally defines a circle.
17. The inhaler according to claim 15 or 16, wherein the at least one of the cooperating surfaces (106: 1 18) is radially directed.
18. The inhaler according to claim 15 or 16, wherein the at least one of the cooperating surfaces (74; 88; 132) is axially directed.
19. The inhaler according to any of claims 12 to 18, further comprising a mouthpiece (2) for gripping in the lips of the user and an inhaler body (6) for housing the dosing means (18), wherein at least a part of the mouthpiece (2) is rotatable relative to the inhaler body (6) and one or both of the mouthpiece (2) and the inhaler body (6) comprise or are attached to the first and second components (66, 68; 80, 82; 100, 102; 1 10, 1 12; 124, 126).
20. The inhaler according to any of claims 12 to 18, comprising a main body having an outlet nozzle (4) and a cap (168) for fitting to the main body when the inhaler is not in use, wherein the cap (168) and the main body comprise or are attached to the first and second components (66, 68; 80, 82; 100, 102; 110, 112; 124, 126).
21. The inhaler according to any of claims 12 to 20 when appendant upon claim 2, wherein at least a part of the surface of the chamber (58) is flexible, which at least part of the surface of the chamber (58) is connected to one of the cooperating surfaces ( 132) and is flexed on relative rotation of the first and second components (124, 126).
22. The inhaler according to claim 21, wherein the at least part of the surface of the chamber (58) is defined by one of the first and second components (124).
23. The inhaler according to claim 21 or 22, wherein the at least part of the surface of the chamber (58) is the surface of the chamber (58) opposed to the inlet thereto.
24. The inhaler according to claim 1 or 2, comprising a main body having an outlet nozzle (4) and a cap (168) for fitting to the main body when the inhaler is not in use, wherein the dislodging means comprises a brush ( 178) which is attached to the cap (168) for insertion into the outlet nozzle (4) when the cap (168) is fitted to the main body.
25. A powder inhaler for administering powder by inhalation, comprising: a housing having a screw thread; a mouthpiece (2) attached to the housing so as to be rotatable relative thereto; and a cap (168) for covering at least the mouthpiece (2), the cap (168) having a screw thread for engaging the screw thread on the housing; characterized in that the mouthpiece (2) and the cap (168) are adapted such that at least a part of the mouthpiece (2) is rotated relative to the housing on one of screwing or unscrewing the cap (168), which part of the mouthpiece (2) remains substantially in fixed position relative to the housing on the other of screwing or unscrewing the cap (168).
26. The inhaler according to claim 25, wherein the mouthpiece (2) and the cap (168) each comprise parts which engage on the one of screwing or unscrewing the cap (168) so as to rotate the at least part of the mouthpiece (2).
27. The inhaler according to claim 26, wherein the engaging parts comprise at least one resiliently-biased member (170; 176) and at least one projection (164) or recess (172), the at least one resiliently-biased member (170; 176) being configured to engage the at least one projection (164) or recess (172) on the one of screwing or unscrewing the cap (168).
28. The inhaler according to any of claims 25 to 27, wherein the at least part of the mouthpiece (2) is rotated relative to the housing on unscrewing the cap (168).
29. The inhaler according to any of claims 25 to 28, wherein the housing comprises a rotatable grip portion (8) which in use is rotated to provide a dose of powder for inhalation, the grip portion (8) being rotated to provide a dose of powder for inhalation in the same sense as that in which the cap (168) is rotated to rotate the at least part of the mouthpiece (2).
30. The inhaler according to any of claims 25 to 29, further comprising means for providing resistance to relative rotation of the at least part of the mouthpiece (2) and the housing.
31. The inhaler according to claim 30, wherein the rotation resistance means allows rotation of the mouthpiece (2) relative to the housing on the other of screwing or unscrewing the cap (168) only for forces greater than that required to rotate the cap (168) on the one of screwing or unscrewing the cap (168).
32. The inhaler according to claim 30 or 31, wherein the rotation resistance means comprises a ratchet mechanism.
33. The inhaler according to claim 31 or 32, wherein the inhaler is configured such that rotation of the at least part of the mouthpiece (2) relative to the housing on the other of screwing or unscrewing the cap (168) causes no damage thereto.
PCT/SE1998/000457 1997-03-14 1998-03-13 Inhalation device WO1998041256A2 (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
TR2000/01837T TR200001837T2 (en) 1997-03-14 1998-03-13 Inhalation device
PL98335799A PL188765B1 (en) 1997-03-14 1998-03-13 Inhalation device
HU0000840A HU223792B1 (en) 1997-03-14 1998-03-13 Inhalation device
DK98909946T DK1017438T3 (en) 1998-03-13 1998-03-13 An inhalation device
SI9830700T SI1017438T1 (en) 1997-03-14 1998-03-13 Inhalation device
CA002283258A CA2283258C (en) 1997-03-14 1998-03-13 Inhalation device
EP98909946A EP1017438B1 (en) 1997-03-14 1998-03-13 Inhalation device
UA99095001A UA68344C2 (en) 1997-03-14 1998-03-13 Powder inhaler
BR9811456-5A BR9811456A (en) 1997-03-14 1998-03-13 Inhalation device
EEP199900403A EE04420B1 (en) 1997-03-14 1998-03-13 Powder inhaler
NZ337478A NZ337478A (en) 1997-03-14 1998-03-13 Inhalation device with accumulated powder on surface of flow path dislodged by vibration
PL98369035A PL190261B1 (en) 1997-03-14 1998-03-13 Powdered inhalation device
KR10-1999-7008296A KR100492839B1 (en) 1997-03-14 1998-03-13 Inhalation device
US09/066,319 US6655380B1 (en) 1997-03-14 1998-03-13 Inhalation device
IL13154798A IL131547A0 (en) 1997-03-14 1998-03-13 Inhalation device
IL16540098A IL165400A0 (en) 1997-03-14 1998-03-13 Inhalation device
AU64303/98A AU741505B2 (en) 1997-03-14 1998-03-13 Inhalation device
SK1234-99A SK285517B6 (en) 1997-03-14 1998-03-13 Inhalation device
JP54042398A JP4138019B2 (en) 1997-03-14 1998-03-13 Inhaler
AT98909946T ATE275998T1 (en) 1997-03-14 1998-03-13 INHALATION DEVICE
DE69826299T DE69826299T2 (en) 1997-03-14 1998-03-13 INHALER
IS5178A IS2780B (en) 1997-03-14 1999-09-13 inhaler
NO19994432A NO321728B1 (en) 1997-03-14 1999-09-13 Innan Dings device
US10/673,689 US7841340B2 (en) 1997-03-14 2003-09-29 Inhaler with powder dislodging member
US11/125,615 US7228860B2 (en) 1997-03-14 2005-05-09 Inhaler with vibrational powder dislodgement
US11/940,346 US7779836B2 (en) 1997-03-14 2007-11-15 Inhalation device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9700937-7 1997-03-14
SE9700937A SE9700937D0 (en) 1997-03-14 1997-03-14 Powder inhales I
SE9703829-3 1997-10-21
SE9703829A SE9703829D0 (en) 1997-10-21 1997-10-21 Powder inhalation

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US09/066,319 A-371-Of-International US6655380B1 (en) 1997-03-14 1998-03-13 Inhalation device
US09/066,319 Continuation US6655380B1 (en) 1997-03-14 1998-03-13 Inhalation device
US10/673,689 Division US7841340B2 (en) 1997-03-14 2003-09-29 Inhaler with powder dislodging member

Publications (2)

Publication Number Publication Date
WO1998041256A2 true WO1998041256A2 (en) 1998-09-24
WO1998041256A3 WO1998041256A3 (en) 1999-02-11

Family

ID=26662934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1998/000457 WO1998041256A2 (en) 1997-03-14 1998-03-13 Inhalation device

Country Status (32)

Country Link
US (4) US6655380B1 (en)
EP (2) EP1017438B1 (en)
JP (1) JP4138019B2 (en)
KR (1) KR100492839B1 (en)
CN (1) CN1247275C (en)
AR (1) AR008957A1 (en)
AT (2) ATE316398T1 (en)
AU (1) AU741505B2 (en)
BR (1) BR9811456A (en)
CA (1) CA2283258C (en)
CZ (1) CZ298388B6 (en)
DE (2) DE69826299T2 (en)
DK (1) DK1454647T3 (en)
EE (2) EE04707B1 (en)
ES (2) ES2256807T3 (en)
HU (1) HU223792B1 (en)
ID (1) ID23498A (en)
IL (2) IL165400A0 (en)
IS (1) IS2780B (en)
MY (1) MY124177A (en)
NO (1) NO321728B1 (en)
NZ (3) NZ337478A (en)
PL (2) PL190261B1 (en)
PT (2) PT1017438E (en)
RU (1) RU2201768C2 (en)
SA (1) SA98190222B1 (en)
SI (1) SI1017438T1 (en)
SK (1) SK285517B6 (en)
TR (2) TR200001837T2 (en)
TW (1) TW469832U (en)
UA (2) UA68344C2 (en)
WO (1) WO1998041256A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6182655B1 (en) 1995-12-07 2001-02-06 Jago Research Ag Inhaler for multiple dosed administration of a pharmacological dry powder
WO2001070318A1 (en) * 2000-03-21 2001-09-27 Astrazeneca Ab An inhalation device
WO2002036163A2 (en) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
US6655380B1 (en) 1997-03-14 2003-12-02 Astrazeneca Ab Inhalation device
US7131441B1 (en) 1995-12-07 2006-11-07 Skyepharma Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US7143765B2 (en) 2001-05-22 2006-12-05 Astrazeneca Ab Inhalation device
US20090159080A1 (en) * 2002-05-09 2009-06-25 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US8230856B2 (en) 2006-01-25 2012-07-31 Valois Sas Mouthpiece for a device for dispensing a fluid product
EP2497513A3 (en) * 2002-09-16 2012-10-17 Sanofi SA Inhalator for powdery, in particular medical, substances
US9572943B2 (en) 2001-09-28 2017-02-21 Kurve Technology, Inc. Particle dispersion device for nasal delivery
EP4059551A1 (en) * 2021-03-18 2022-09-21 Funai Electric Co., Ltd. Pharmaceutical drug delivery device, and method of air flow and humidity control thereof

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0858940A (en) * 1994-08-25 1996-03-05 Mukai Kogyo Kk Conveyer device
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2226721T3 (en) * 2000-06-13 2005-04-01 Andi-Ventis Limited ORAL PIECE FOR PARTICLE INHALER.
ES2300568T3 (en) 2002-03-20 2008-06-16 Mannkind Corporation INHALATION APPARATUS
AU2005221383B2 (en) 2004-03-10 2010-07-22 Glaxo Group Limited A dispensing device
MX2007001903A (en) 2004-08-20 2007-08-02 Mannkind Corp Catalysis of diketopiperazine synthesis.
KR101306384B1 (en) 2004-08-23 2013-09-09 맨카인드 코포레이션 Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
BRPI0613034A8 (en) 2005-07-14 2018-01-02 Lipothera Inc injectable formulation for fat tissue accumulation, injectable formulation and method for treating fat accumulation, and method for reducing fat tissue.
JP5465878B2 (en) 2005-09-14 2014-04-09 マンカインド コーポレイション Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
JP4934678B2 (en) * 2005-12-23 2012-05-16 アストラゼネカ・アクチエボラーグ New device
US20070181119A1 (en) * 2006-02-08 2007-08-09 Weinstein Robert E Inhaler Device
CN104383546B (en) 2006-02-22 2021-03-02 曼金德公司 Method for improving the pharmaceutical properties of microparticles comprising diketopiperazines and an active agent
US8127763B2 (en) * 2006-03-03 2012-03-06 Stc.Unm Dry powder inhaler with aeroelastic dispersion mechanism
JP5188991B2 (en) * 2006-03-03 2013-04-24 エスティーシー.ユーエヌエム Dry powder inhaler with aeroelastic distribution mechanism
CN101484201B (en) * 2006-06-27 2011-06-15 大冢制药株式会社 Powder inhaler
US20100139655A1 (en) * 2006-11-19 2010-06-10 Aespironics Ltd Dry-powder inhaler
EP2230934B8 (en) 2007-12-14 2012-10-24 AeroDesigns, Inc Delivering aerosolizable food products
CN104689432B (en) 2008-06-13 2018-07-06 曼金德公司 Diskus and the system for drug conveying
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5479465B2 (en) 2008-06-20 2014-04-23 マンカインド コーポレイション Interactive device and method for profiling inhalation efforts in real time
TWI494123B (en) 2008-08-11 2015-08-01 Mannkind Corp Use of ultrarapid acting insulin
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (en) 2009-03-11 2014-04-30 Mannkind Corp Apparatus, system and method for measuring resistance of an inhaler
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
EP2440184B1 (en) 2009-06-12 2023-04-05 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
NZ596456A (en) * 2009-06-25 2014-01-31 Boehringer Ingelheim Vetmed Inhaler
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US9492625B2 (en) 2009-11-12 2016-11-15 Stc.Unm Dry powder inhaler with flutter dispersion member
RU2571331C1 (en) 2010-06-21 2015-12-20 Маннкайнд Корпорейшн Systems and methods for dry powder drug delivery
CA2815374A1 (en) 2010-11-24 2012-06-07 Lithera, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
US8561609B2 (en) 2010-12-07 2013-10-22 Respira Therapeutics, Inc. Dry powder inhaler
DK2694402T3 (en) 2011-04-01 2017-07-03 Mannkind Corp BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
WO2012171443A1 (en) * 2011-06-13 2012-12-20 上海秀新臣邦医药科技有限公司 Dry powder drug administration device
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
BR112016000937A8 (en) 2013-07-18 2021-06-22 Mannkind Corp dry powder pharmaceutical formulations, method for making a dry powder formulation and use of a dry powder pharmaceutical formulation
JP2016530930A (en) 2013-08-05 2016-10-06 マンカインド コーポレイション Ventilation device and method
PL3035886T3 (en) 2013-08-20 2021-05-31 Boehringer Ingelheim Vetmedica Gmbh Inhaler
PT3035887T (en) 2013-08-20 2020-04-02 Boehringer Ingelheim Vetmedica Gmbh Inhaler
EP3035885B1 (en) 2013-08-20 2019-12-25 Boehringer Ingelheim Vetmedica GmbH Inhaler
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CA2972826C (en) 2015-01-14 2023-09-12 Respira Therapeutics, Inc. Powder dispersion methods and devices
US11116918B2 (en) 2015-03-02 2021-09-14 Abithas, Inc. Delivery system for metered dose inhalers
US20160256641A1 (en) * 2015-03-02 2016-09-08 Edward Lisberg Delivery System for Metered Dose Inhalers
CN205322939U (en) * 2015-10-27 2016-06-22 深圳市杰仕博科技有限公司 Thermal -insulated suction nozzle
US10512921B2 (en) * 2016-05-09 2019-12-24 Funai Electric Co., Ltd. Maintenance apparatus for vaporizing device
CN109821118A (en) * 2017-11-23 2019-05-31 正大天晴药业集团股份有限公司 Novel lung delivery system
CN114209494B (en) * 2021-12-02 2023-11-10 江西省儿童医院 Atomizing therapeutic device for treating pinkeye for ophthalmology

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE25422C (en) * J. HASSLER in Baden - Soden, Reg.-Bez. Wiesbaden Apparatus for atomizing powdery substances for inhalation purposes
US2470297A (en) * 1947-09-04 1949-05-17 Abbott Lab Inhalator
GB1118341A (en) * 1965-04-20 1968-07-03 Fisons Pharmaceuticals Ltd Inhalation device
GB2179260A (en) * 1985-08-01 1987-03-04 Hurka Wilhelm Inhaler
EP0424790A2 (en) * 1989-10-27 1991-05-02 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
WO1994008552A2 (en) * 1992-10-19 1994-04-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
WO1994014492A2 (en) * 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
DE4415462C1 (en) * 1994-05-03 1995-08-31 Transcoject Marketing Gmbh Inhaler for powdered medicine etc.
WO1997030743A2 (en) * 1996-02-21 1997-08-28 Schering Corporation Powdered medication inhaler

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470296A (en) 1948-04-30 1949-05-17 Abbott Lab Inhalator
US2573918A (en) 1949-11-05 1951-11-06 Vick Chemical Company Device for dispensing medicaments
GB1295081A (en) 1969-01-08 1972-11-01 Fisons Pharmaceuticals Ltd A method and device for dispensing particulate medicament material from a container
GB1459426A (en) 1973-02-26 1976-12-22 Allen & Hanburys Ltd Inhalation devices
US3948264A (en) 1975-05-21 1976-04-06 Mead Johnson & Company Inhalation device
SE411705B (en) 1976-11-09 1980-02-04 Draco Ab DEVICE FOR GENERATION OF A SHIELD, ESSENTIAL FUEL-FREE AEROSOL
JPS608907B2 (en) 1978-12-19 1985-03-06 新日本製鐵株式会社 Narrow gap submerged arc welding method
SE438261B (en) * 1981-07-08 1985-04-15 Draco Ab USE IN A DOSHALATOR OF A PERFORED MEMBRANE
CY1492A (en) 1981-07-08 1990-02-16 Draco Ab Powder inhalator
US4805811A (en) * 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
US4811731A (en) * 1985-07-30 1989-03-14 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (en) 1986-03-07 1988-02-15 Draco Ab POWDER INHALATOR DEVICE
US4739754A (en) 1986-05-06 1988-04-26 Shaner William T Suction resistant inhalator
SE466684B (en) * 1989-03-07 1992-03-23 Draco Ab DEVICE INHALATOR AND PROCEDURE TO REGISTER WITH THE DEVICE INHALATOR MEDICATION
ES2087911T3 (en) * 1989-04-28 1996-08-01 Riker Laboratories Inc DRY DUST INHALATION DEVICE.
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5201308A (en) * 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
US5113855A (en) * 1990-02-14 1992-05-19 Newhouse Michael T Powder inhaler
NZ238489A (en) 1990-06-14 1995-09-26 Rhone Poulenc Rorer Ltd Inhaler with capsule in swirling chamber: capsule pierced in chamber
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
DE4027391A1 (en) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg GAS-FREE INHALATION DEVICE
AU657492B2 (en) 1990-09-12 1995-03-16 Hans Bisgaard An inhaling device
US5429122A (en) * 1990-09-26 1995-07-04 Zanen; Pieter Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
DE69132850T2 (en) 1990-09-26 2002-05-29 Pharmachemie Bv Cyclone powder inhaler
US5243970A (en) * 1991-04-15 1993-09-14 Schering Corporation Dosing device for administering metered amounts of powdered medicaments to patients
CZ282291B6 (en) 1991-06-26 1997-06-11 Schering Corporation Inhalator for powder substances
US5203323A (en) * 1991-07-02 1993-04-20 Tritle Paul E Metered dose inhaler spacer device and associated cleaning brush
DE69331635T2 (en) 1992-11-12 2002-10-31 Minnesota Mining & Mfg powder inhaler
AT398277B (en) 1992-12-11 1994-11-25 Hurka Wilhelm INHALATION DEVICE
US5437271A (en) 1993-04-06 1995-08-01 Minnesota Mining And Manufacturing Company Deagglomerators for dry powder inhalers
US5372128A (en) * 1993-04-14 1994-12-13 Habley Medical Technology Corporation Fluidizing powder inhaler
SE9302550D0 (en) * 1993-07-30 1993-07-30 Ernst Hoerlin POWDER INHALES
AU1752795A (en) 1994-03-10 1995-09-25 Franco Del Bon Inhalator
US6102036A (en) * 1994-04-12 2000-08-15 Smoke-Stop Breath activated inhaler
GB9419269D0 (en) 1994-09-23 1994-11-09 Unilever Plc Aerosol
SE9404439D0 (en) * 1994-12-21 1994-12-21 Astra Ab Inhalation device
FR2738152B1 (en) * 1995-09-04 1998-01-23 Tebro POWDER PRODUCT PREDOSING DEVICE FOR A PRODUCT DISPENSER
SE9700948D0 (en) * 1997-03-14 1997-03-14 Astra Ab Powder inhales X
TW469832U (en) 1997-03-14 2001-12-21 Astra Ab Inhalation device
SE9700937D0 (en) * 1997-03-14 1997-03-14 Astra Ab Powder inhales I
SE9801114D0 (en) * 1998-03-30 1998-03-30 Astra Ab Inhalation device

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE25422C (en) * J. HASSLER in Baden - Soden, Reg.-Bez. Wiesbaden Apparatus for atomizing powdery substances for inhalation purposes
US2470297A (en) * 1947-09-04 1949-05-17 Abbott Lab Inhalator
GB1118341A (en) * 1965-04-20 1968-07-03 Fisons Pharmaceuticals Ltd Inhalation device
GB2179260A (en) * 1985-08-01 1987-03-04 Hurka Wilhelm Inhaler
EP0424790A2 (en) * 1989-10-27 1991-05-02 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
WO1994008552A2 (en) * 1992-10-19 1994-04-28 Dura Pharmaceuticals, Inc. Dry powder inhaler
WO1994014492A2 (en) * 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
DE4415462C1 (en) * 1994-05-03 1995-08-31 Transcoject Marketing Gmbh Inhaler for powdered medicine etc.
WO1997030743A2 (en) * 1996-02-21 1997-08-28 Schering Corporation Powdered medication inhaler

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7131441B1 (en) 1995-12-07 2006-11-07 Skyepharma Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US6182655B1 (en) 1995-12-07 2001-02-06 Jago Research Ag Inhaler for multiple dosed administration of a pharmacological dry powder
US7228860B2 (en) 1997-03-14 2007-06-12 Astrazeneca Ab Inhaler with vibrational powder dislodgement
US7841340B2 (en) 1997-03-14 2010-11-30 Astrazeneca Ab Inhaler with powder dislodging member
US7779836B2 (en) 1997-03-14 2010-08-24 Astrazeneca Ab Inhalation device
US6655380B1 (en) 1997-03-14 2003-12-02 Astrazeneca Ab Inhalation device
WO2001070318A1 (en) * 2000-03-21 2001-09-27 Astrazeneca Ab An inhalation device
US6892728B2 (en) 2000-03-21 2005-05-17 Astrazeneca Ab Inhalation device
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
WO2002036163A3 (en) * 2000-10-31 2002-12-12 Boehringer Ingelheim Pharma Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
WO2002036163A2 (en) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions consisting of tiotropium salts and antihistamines for treating respiratory illnesses
US7143765B2 (en) 2001-05-22 2006-12-05 Astrazeneca Ab Inhalation device
US9572943B2 (en) 2001-09-28 2017-02-21 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US9352106B2 (en) 2002-05-09 2016-05-31 Kurve Technology, Inc. Particle dispersion device for nasal delivery
US20090159080A1 (en) * 2002-05-09 2009-06-25 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
US10668230B2 (en) * 2002-05-09 2020-06-02 Kurve Technology, Inc. Particle dispersion chamber for nasal nebulizer
EP2497513A3 (en) * 2002-09-16 2012-10-17 Sanofi SA Inhalator for powdery, in particular medical, substances
US8342174B2 (en) 2002-09-16 2013-01-01 Sanofi Sa Inhaler for powdery substances, in particular medicinal substances
US8342175B2 (en) 2002-09-16 2013-01-01 Sanofi Sa Inhaler for powdery substances, in particular medicinal substances
US8978646B2 (en) 2002-09-16 2015-03-17 Sanofi Sa Inhaler for powdery substances, in particular medicinal substances
US8230856B2 (en) 2006-01-25 2012-07-31 Valois Sas Mouthpiece for a device for dispensing a fluid product
EP4059551A1 (en) * 2021-03-18 2022-09-21 Funai Electric Co., Ltd. Pharmaceutical drug delivery device, and method of air flow and humidity control thereof

Also Published As

Publication number Publication date
RU2201768C2 (en) 2003-04-10
EE04707B1 (en) 2006-10-16
TR200001837T2 (en) 2001-10-22
AU6430398A (en) 1998-10-12
US7841340B2 (en) 2010-11-30
WO1998041256A3 (en) 1999-02-11
TW469832U (en) 2001-12-21
CN1255867A (en) 2000-06-07
KR20000076202A (en) 2000-12-26
NO994432L (en) 1999-11-03
MY124177A (en) 2006-06-30
DE69833286T2 (en) 2006-11-02
US20050194008A1 (en) 2005-09-08
NO994432D0 (en) 1999-09-13
AU741505B2 (en) 2001-12-06
HUP0000840A3 (en) 2000-09-28
DE69833286D1 (en) 2006-04-13
ATE275998T1 (en) 2004-10-15
NO321728B1 (en) 2006-06-26
EP1017438B1 (en) 2004-09-15
UA89608C2 (en) 2010-02-25
PT1454647E (en) 2006-05-31
BR9811456A (en) 2000-09-19
EP1454647A3 (en) 2004-11-17
IS2780B (en) 2012-05-15
NZ513357A (en) 2003-03-28
US20080092886A1 (en) 2008-04-24
JP2001517980A (en) 2001-10-09
SK123499A3 (en) 2000-05-16
IL131547A0 (en) 2001-01-28
EE04420B1 (en) 2005-02-15
EP1017438A2 (en) 2000-07-12
PL190261B1 (en) 2005-11-30
US20040065325A1 (en) 2004-04-08
CZ324299A3 (en) 2000-03-15
UA68344C2 (en) 2004-08-16
CZ298388B6 (en) 2007-09-19
CA2283258A1 (en) 1998-09-24
IL165400A0 (en) 2006-01-15
IS5178A (en) 1999-09-13
SK285517B6 (en) 2007-03-01
HUP0000840A2 (en) 2000-08-28
EE9900403A (en) 2000-04-17
KR100492839B1 (en) 2005-06-07
ID23498A (en) 2000-04-27
DE69826299T2 (en) 2005-08-18
US7779836B2 (en) 2010-08-24
SA98190222B1 (en) 2006-06-10
EP1454647A2 (en) 2004-09-08
EP1454647B1 (en) 2006-01-25
DK1454647T3 (en) 2006-05-08
PL188765B1 (en) 2005-04-29
PL335799A1 (en) 2000-05-22
TR199902240T2 (en) 1999-12-21
SI1017438T1 (en) 2005-02-28
EE200400122A (en) 2005-02-15
US7228860B2 (en) 2007-06-12
AR008957A1 (en) 2000-02-23
ES2256807T3 (en) 2006-07-16
DE69826299D1 (en) 2004-10-21
US6655380B1 (en) 2003-12-02
NZ337478A (en) 2001-09-28
HU223792B1 (en) 2005-01-28
ES2227812T3 (en) 2005-04-01
ATE316398T1 (en) 2006-02-15
CN1247275C (en) 2006-03-29
JP4138019B2 (en) 2008-08-20
PT1017438E (en) 2004-12-31
NZ523896A (en) 2004-08-27
CA2283258C (en) 2007-07-17

Similar Documents

Publication Publication Date Title
US6655380B1 (en) Inhalation device
AU723699B2 (en) Inhalation device
US6142145A (en) Inhalation device
US8025051B2 (en) Delivery device
AU754389B2 (en) Inhalation device with a dose counting unit
US6325061B1 (en) Inhalation device
WO1998041258A1 (en) Inhalation device
MXPA00009213A (en) Inhalation device

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 131547

Country of ref document: IL

Ref document number: 98805080.3

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 09066319

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 64303/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 337478

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/008235

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2283258

Country of ref document: CA

Ref document number: 2283258

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 123499

Country of ref document: SK

ENP Entry into the national phase

Ref document number: 1998 540423

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1999-3242

Country of ref document: CZ

Ref document number: 1019997008296

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1999/02240

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 1998909946

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1999-3242

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: 2000/01837

Country of ref document: TR

WWP Wipo information: published in national office

Ref document number: 1998909946

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019997008296

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 64303/98

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 1998909946

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 165400

Country of ref document: IL

WWG Wipo information: grant in national office

Ref document number: 1019997008296

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: PV1999-3242

Country of ref document: CZ